NCT05626829View on ClinicalTrials.gov

Tranilast as a Radiosensitizer in Reradiation of Nasopharyngeal Carcinoma

PHASE2RecruitingINTERVENTIONAL

Enrollment

18

Participants

Timeline

Start Date

July 20, 2022

Primary Completion Date

July 20, 2024

Study Completion Date

November 30, 2024

Conditions

Nasopharyngeal CarcinomaRecurrent Cancer

Interventions

DRUG

Tranilast

Tranilast capsules 100mg 3 times per day when reradiation

Trial Locations (1)

510515

RECRUITING

Southern medical university, Guangzhou

All Listed Sponsors

lead

Jian Guan

OTHER